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The Beneficial Amalgamation of Technology and Neurology 
By Danielle Long 
Every second thousands of lightning-fast electrical impulses are being transported across 
synaptic connections between neurons in the brain. For the millions of people worldwide who 
suffer neurological conditions, such as epilepsy, each one of these electrical signals carries with 
it the harrowing threat of triggering a life-threatening seizure. Serving as a volunteer at Carle 
Foundation Hospital in Urbana, Illinois for the past four summers, I have had the privilege of 
working with several resilient epilepsy patients who are desperate for reprieve from their 
condition. Communicating with these patients and hearing their stories sparked my curiosity 
about the treatment of epilepsy. As an aspiring nurse practitioner, I asked myself, what if these 
patients were able to eradicate this threat by acquiring the ability to predict, control, and even 
prevent these seizure-causing impulses? In researching this profound question, I made an 
intriguing discovery. 
Astonishingly, technology with these miraculous abilities does indeed exist in the form of 
a neurologic implantation device with the power to monitor brain activity and forestall the onset 
of a seizure. This neoteric, innovative technology is known as the NeuroPace Responsive 
Neurostimulation Device, or the NeuroPace RNS System (“The RNS System”). The device is a 
small appliance, about the size and shape of an oversized flashdrive, which is surgically 
implanted on the surface of the skull or the outer tissue of the brain (Scott). Once inserted, the 
device immediately begins scanning brain activity, and if abnormal activity is sensed by the 
NeuroPace RNS system, the device fires electrically stimulating impulses to impede the onset of 
the seizure and prevent the injurious electrical impulses from triggering other irregular neural 
activity in surrounding regions of the brain (“The RNS System”). Miraculously, physicians have 
harnessed the device’s functionally to bring alternative treatment, in the place of intrusive Long | 1 
 
prescription treatment plans, to epilepsy patients suffering from unremitting, recurrent seizures. 
This has brought about an exciting movement in the neurology field and afforded hope to 
patients (Scott). In this manner, the NeuroPace RNS System exemplifies a revolutionary 
technological innovation in which epilepsy patients are able to reap tremendous benefits, both 
medically and psychologically.   
With its unique design and its preventative abilities, the NeuroPace RNS System is unlike 
any electrical simulation device of its kind, being comparable only to the cardiac pacemaker. 
Much like the cardiac pacemaker regulates irregularities in the electrical impulses that allow for 
the rhythmic beating of the heart, the NeuroPace device combats perilous electrical activity in 
the brain and responds to the threat of a seizure. However, unlike the cardiac pacemaker, the 
NeuroPace RNS System has the additional ability to store the monitored brain activity (“FAQ: 
NeuroPace”).  This data can be digitally uploaded, shared, and viewed by patients and their 
physicians using computer software called the Patient Data Management System, or PDMS 
(“The RNS System”). Before the fabrication of the NeuroPace RNS system, neurologists had to 
rely on patient accounts for the details on the duration and severity of the seizures, since there 
was no way for the physician to continually monitor the patient without having them hooked up 
to an external brain monitoring device such as an electroencephalogram, or EEG (Scott). 
Therefore, because of the constant monitoring capabilities that the NeuroPace device offers, it 
serves as an invaluable advancement in neurological technology.  
In addition to providing constant monitoring and targeted neurostimulation, the 
NeuroPace device significantly improves the quality of life for epilepsy patients who have 
previously been on a regimented treatment plan that required taking potent anti-seizure 
medications. Unfortunately, anti-seizure medications can have serious side effects, depending 
upon the patient and his or her specific medical background (“The RNS System”). I found this to Long | 2 
 
be the case for many of the patients I have spoken with while volunteering. Many of the patients 
reported that oftentimes the side effects of their medication are so severe that they are unable to 
leave their house until the medication dosage has been titrated down. The most commonly 
reported side effects of seizure-combative drugs are dizziness, headaches, drowsiness, reduced 
cognitive abilities, and even memory loss (Cass). Epileptic patients that experience these 
hampering side effects, including patients that I have worked with, are unable to participate in 
many of the activities of daily life, such as driving. The NeuroPace RNS System alleviates this 
burden by reducing the frequency of seizures and providing an alternative to potent medications 
so that epilepsy patients are able to feel in control of how they live their lives. Whereas anti-
seizure medications deliver treatment continuously in the bloodstream when the patient takes 
them, the NeuroPace device only provides treatment when it deems necessary to prevent the 
initiation of a seizure (Cass). This makes the NeuroPace device evolutionary in the process of 
preventing seizures in patients that have previously struggled with severe, unpredictable seizures 
that disrupt their lifestyle.  
According to statistics from the Epilepsy Foundation, approximately one-hundred and 
fifty thousand people develop epilepsy each year; therefore, the NeuroPace RNS system can 
have a significant impact on the lives of many people living with the neurological condition 
(Shafer and Sirven). Take, for example, the case of a young man that I worked with while 
volunteering (let’s call him Andy) who has recently received the NeuroPace device. Andy was 
diagnosed with epilepsy roughly six years ago when he was seventeen years old; he suffered 
several episodes of seizures a week, which meant that he could no longer live the life of a typical 
teenager. He often missed school when he had to seek medical attention, and he could no longer 
drive. The seizures were severe and he lost a significant amount of brain matter, which greatly 
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impaired his academic growth. When he began taking anti-seizure medication, the side effects 
were nearly unbearable.  
While the medication was successful in reducing the frequency of his seizures, Andy 
reported that he felt as though he was in a perpetual hazy state in which his thoughts and memory 
were unclear. He eventually decided to stop taking the medication, but found that he relapsed 
into having recurrent seizures and was forced to begin taking the medication again. However, 
now, roughly six years later, Andy has decided to go forth with the implantation of the 
NeuroPace device. With the device, he has significantly fewer intermittent seizures and he no 
longer has to take his potent anti-seizure medication, which has allowed him to begin driving 
again and to go back to school to earn his bachelor’s degree. Andy’s story is just one example of 
the many noteworthy benefits that the NeuroPace device has had in the lives of epilepsy patients, 
and it is my hope that his story will encourage other epilepsy patients to consider the NeuroPace 
device as a means of improving the quality of their own lives.  
Although the NeuroPace device has many benefits, there are some downfalls of the 
system in terms of its ability to serve as the primary treatment plan for seizure-prone patients. 
For some patients, the risk associated with the invasive aspect of the implantation of the 
NeuroPace device makes them hesitant or ineligible (“FAQ: NeuroPace”). Also, because the 
NeuroPace device is battery operated, the device must be replaced every two and a half to three 
years; however, this requires only a small incision near the scalp, only large enough to remove 
the old device and replace it with a new one, and it does not require the reinstallation of the wires 
(“The RNS System”). The cost of the initial surgery also poses a problem for some patients, 
seeing as the combined cost of the device and the neurosurgery is nearly forty thousand dollars 
(Singh). But there is hope for patients facing financial strain, as many major insurance 
companies are now providing coverage for the surgery. In addition, as noted by the CEO of Long | 4 
 
NeuroPace, Frank Fisher, the operation “pays for itself” in that it reduces the frequency of 
seizures, limits the number of hospital visits, and improves the quality of life for epilepsy 
patients (Cass).  
There are of course risks associated with the surgery itself, as well, such as the chance of 
unintentionally damaging surrounding brain tissue, resulting in irreversible cognitive 
impairment. In addition, although there have been no severe cases in the implantations thus far, 
there is the chance that the device could fire ineffectively or, when treatment is not needed, cause 
inadvertent effects (Cass). There is also the question presented by many patients regarding the 
interaction between the device and other electronics, such as cell phones. The NeuroPace 
Company assures patients considering the installation of the device that there is no evidence in 
the research done thus far that indicates that electronics, other than the computer software 
program used specifically for the NeuroPace RNS system, have an impact on the device’s 
functioning (“The RNS System”). 
Although the NeuroPace RNS system does not cure epilepsy, it does serve as a 
monumental technological movement in neurology. As chairman of the Epilepsy Foundation, 
Warren Lammert, avows, “The RNS System from NeuroPace integrates the best of technology 
and neurology, and is an important new treatment option for these individuals and their families” 
(Radcliff). The NeuroPace device not only provides patients with a sense of control over the 
treatment of their condition, but it provides them with hope for a better life, a life consumed less 
by seizures. Although (like life in general) there are no certainties in medicine, the NeuroPace 
device offers the chance of significantly enhanced quality of life. 
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